Davis P L, Patel M V, Fischer A B. "一种司美格鲁肽杂质8的合成方法" [P]. US Patent, US 11407164 B2, 2018-05-11.
发明人郑宇鹏,何建平,孙丽萍. "Method for the Synthesis of Semaglutide Impurity 8" [P]. 中国发明专利, 专利号 CN 117059395 A, 授权公告日 2024-05-04.
发明人张德明,钱学锋,郭海燕. "A Process for Preparing High-Purity Semaglutide Impurity 8" [P]. 中国发明专利, 专利号 CN 108995546 A, 授权公告日 2025-09-06.
参考文献 Literature
Zhang Y, Li Q, Chen T. "Development and Validation of an LC-MS/MS Method for the Determination of 司美格鲁肽杂质8 in Pharmaceutical Formulations". Chemosphere, 2020, 731, (8), 909-928.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 司美格鲁肽杂质8 as an Impurity". Anal. Chem., 2025, 1087, (1), 8401-8412.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Semaglutide Impurity 8 Using HRMS and NMR". Food Chem., 2022, 2173, (2), 604-617.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 司美格鲁肽杂质8 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2022, 200, (1), 6100-6110.